Distribution of biotypes and antimicrobial susceptibility of Actinobacillus actinomycetemcomitans.
Eighty isolates of Actinobacillus actinomycetemcomitans from 30 Brazilian periodontitis patients were examined to determine the distribution of biotypes and in vitro antimicrobial susceptibility. Seventy-seven percent of the isolates belonged to biotype X. All A. actinomycetemcomitans isolates were susceptible to cefoxitin, imipenem and tetracycline.
Avila-Campos
M J
MJ
Department of Microbiology, Instituto de Ciências Biomédicas, Universidade de São Paulo, Brazil.
Carvalho
M A
MA
Zelante
F
F
D000293:Adolescent; D000328:Adult; D016976:Aggregatibacter actinomycetemcomitans / Q000145:classification* / Q000187:drug effects*; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000994:Antitrichomonal Agents / Q000494:pharmacology; D015373:Bacterial Typing Techniques; D002440:Cefoxitin / Q000494:pharmacology; D002513:Cephamycins / Q000494:pharmacology; D002981:Clindamycin / Q000494:pharmacology; D003773:Dental Plaque / Q000382:microbiology; D004352:Drug Resistance, Microbial; D004917:Erythromycin / Q000494:pharmacology; D005260:Female; D006801:Humans; D015378:Imipenem / Q000494:pharmacology; D008034:Lincomycin / Q000494:pharmacology; D008297:Male; D008795:Metronidazole / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D010400:Penicillin G / Q000494:pharmacology; D010406:Penicillins / Q000494:pharmacology; D010518:Periodontitis / Q000382:microbiology*; D013752:Tetracycline / Q000494:pharmacology; D013845:Thienamycins / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D000994:Antitrichomonal Agents; D002513:Cephamycins; D010406:Penicillins; D013845:Thienamycins; D008795:Metronidazole; D002981:Clindamycin; D004917:Erythromycin; D002440:Cefoxitin; D015378:Imipenem; D008034:Lincomycin; D013752:Tetracycline; D010400:Penicillin G